Characteristics | Complete TACE | Incomplete TACE | P-value | ||
---|---|---|---|---|---|
Curative Tx | SABR | Non-curative Tx | |||
Age | Â | Â | Â | Â | 0.622 |
 Range (median, years) | 41–83 (55) | 35–77 (60) | 42–74 (59) | 24–84 (59) |  |
Sex | Â | Â | Â | Â | 0.426 |
 Male | 14 (58) | 33 (70) | 29 (78) | 49 (70) |  |
 Female | 10 (42) | 14 (30) | 8 (22) | 21 (30) |  |
BCLC stage | Â | Â | Â | Â | 0.135 |
 0 | 9 (38) | 8 (17) | 6 (16) | 12 (17) |  |
 A | 15 (63) | 39 (83) | 31 (84) | 58 (83) |  |
CTP score | Â | Â | Â | Â | 0.040 |
 5 | 18 (75) | 42 (89) | 26 (70) | 47 (67) |  |
 6 | 3 (13) | 5 (11) | 7 (19) | 16 (23) |  |
 7 | 3 (13) | 0 ( 0) | 4 (11) | 7 (10) |  |
Tumor size | Â | Â | Â | Â | 0.073 |
 Range (median, cm) | 0.5–8 (2.1) | 1–8 (2.8) | 0.8–10 (3.4) | 0.5–10 (3.8) |  |
 0.1–3.0 cm | 19 (79) | 32 (68) | 18 (49) | 36 (51) |  |
 3.1–10.0 cm | 5 (21) | 15 (32) | 19 (51) | 34 (49) |  |